Company / Shares Outstanding
Insight Molecular Diagnostics Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
17.5M
FY2025
5-year range
5.9M / 92.2M
FY2021-FY2025
Trend
+111.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 5932191.00 to 17452824.00 over the past 2 years.
Based on SEC 10-K filings.
17452824.00 in FY2025 with a 5-year CAGR of -21.1%.
Increased from 5932191.00 to 17452824.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -42.6%
- 5-Year CAGR
- -21.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 111.3% year-over-year.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.5M | +111.3% |
| FY2024 | 8.3M | +39.3% |
| FY2023 | 5.9M | -93.6% |
| FY2022 | 92.2M | +33.4% |
| FY2021 | 69.1M | +21.2% |
| FY2020 | 57.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026